This is a preview of subscription content, log in via an institution to check access.
Notes
2009 US dollars
Reference
Poonawalla IB, et al. Cost-Effectiveness of Neoadjuvant Chemotherapy versus Primary Surgery in Elderly Patients with Advanced Ovarian Cancer. Value in Health 18: 387-95, No. 4, Jun 2015
Rights and permissions
About this article
Cite this article
Neoadjuvant chemotherapy cost effective in high-risk patients. PharmacoEcon Outcomes News 731, 25 (2015). https://doi.org/10.1007/s40274-015-2254-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2254-z